{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Gail R. Wilensky, one of the Republican Party's top health care experts, is losing her job as chairwoman of an influential commission that advises Congress on Medicare, in part because of concerns about her substantial investments in health care companies. Dr. Wilensky was an adviser to George W. Bush in the presidential campaign and worked for Mr. Bush's father as head of the federal agency that runs Medicare and Medicaid. She has been chairwoman of the Medicare Payment Advisory Commission and one of its predecessor panels since 1995.", "headline": {"main": "Medicare Panel Head Is Replaced as Holdings Are Questioned"}, "abstract": "Gail R Wilensky, one of Republican Party's top health care experts, is losing her job as chairwoman of influential Medicare Payment Advisory Commission that advises Congress on Medicare, in part because of her substantial investments in health care companies (M)", "print_page": "16", "word_count": 576, "_id": "4fd249ec8eb7c8105d7e7a46", "snippet": "Gail R. Wilensky, one of the Republican Party's top health care experts, is losing her job as chairwoman of an influential commission that advises Congress on Medicare, in part because of concerns about her substantial investments in health care...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2001/05/15/us/medicare-panel-head-is-replaced-as-holdings-are-questioned.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "persons", "value": "WILENSKY, GAIL R"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robert", "lastname": "PEAR"}], "original": "By ROBERT PEAR"}, "document_type": "article", "pub_date": "2001-05-15T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Note: This lesson was originally published on an older version of The Learning Network; the link to the related Times article will take you to a page on the old site.", "headline": {"main": "Special Treatment", "kicker": "The Learning Network"}, "abstract": "In this lesson, students determine the role of the FDA in approving new drugs. They then investigate some of these new drugs and consider the pros and cons of taking part in a clinical study.", "print_page": null, "word_count": 2050, "_id": "4fd363a08eb7c8105d8b2454", "snippet": "In this lesson, students determine the role of the FDA in approving new drugs. They then investigate some of these new drugs and consider the pros and cons of taking part in a clinical study.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://learning.blogs.nytimes.com/2001/05/15/special-treatment/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": null, "document_type": "blogpost", "pub_date": "2001-05-15T00:00:00Z", "section_name": "U.S."}], "meta": {"hits": 22, "offset": 20, "time": 37}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}